Dimension Therapeutics' Seed VC Round

Dimension Therapeutics raised a round of funding on November 18, 2013. Investors include F-Prime Capital.

Dimension Therapeutics is focused on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia, and building out a world-…

Articles about Dimension Therapeutics' Seed VC Round: